Scribe Therapeutics Inc.

Scribe Therapeutics Inc.

NNASDAQ:SCTX
15.77
USD
+0.40
(+2.60%)
-0.40EPS
Mar 03Next Earn

Scribe Therapeutics Inc. Documents

Q2 FY2026 · Quarterly report

September 2, 2026 · 115 pages

Read Scribe Therapeutics Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q2 FY2026 documents